Stroke Trial, Recruiting (NCT05706831)

Stroke Trial, Recruiting NCT05706831 Sponsor: Istituti Clinici Scientifici Maugeri SpA Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT05706831 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are older than 18 years of age
People who have developed difficulty with language or communication (aphasia) after a stroke
People who have developed a condition after a stroke where they have trouble paying attention to one side of their body or environment (neglect)
People who have a reduced level of awareness or consciousness following a brain injury or illness

Who may not be able to join:

People who have a hearing injury or hearing loss (confirm with trial site)
People who have a history of a neurological condition (a condition affecting the brain or nervous system, other than the stroke itself)
People who have a history of a psychiatric condition (a mental health condition)
People who have had a previous stroke before the current one
People who currently use alcohol or drugs at a significant level (confirm with trial site)
People who had dementia before their stroke or brain injury occurred

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +393332783524

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05706831

Sponsor: Istituti Clinici Scientifici Maugeri SpA

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: +393332783524

More information: https://clinicaltrials.gov/study/NCT05706831

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are older than 18 years of age
People who have developed difficulty with language or communication (aphasia) after a stroke
People who have developed a condition after a stroke where they have trouble paying attention to one side of their body or environment (neglect)
People who have a reduced level of awareness or consciousness following a brain injury or illness

Who may not be able to join:

People who have a hearing injury or hearing loss (confirm with trial site)
People who have a history of a neurological condition (a condition affecting the brain or nervous system, other than the stroke itself)
People who have a history of a psychiatric condition (a mental health condition)
People who have had a previous stroke before the current one
People who currently use alcohol or drugs at a significant level (confirm with trial site)
People who had dementia before their stroke or brain injury occurred

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Istituti Clinici Scientifici Maugeri SpA

Registry

ClinicalTrials.gov

Start date

1 September 2022

Est. completion

31 December 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Neuropsychological outcomes; Neuropsychological outcomes; Neuropsychological outcomes; Neuropsychological outcomes; Neuropsychological outcomes; Neuropsychological outcomes; Neuropsychological outcomes; Neuropsychological outcomes; Neuropsychological outcomes; Neuropsychological outcomes; Neuropsychological outcomes; Neuropsychological outcomes; Neuropsychological outcomes; Neuropsychological outcomes; Neurophysiological outcome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov